Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

AZ says cancer will be ‘sixth growth platform’

Firm currently has 14 drugs in phase III trials

- PMLiVE

Merck’s ezetimibe has ‘modest’ benefit when added to statins

Combination showed a reduction in cardiovascular events in patients with ACS

- PMLiVE

Creston Health rebrands under Health Unlimited banner

Agencies including Red Door and PAN will operate separately and together

- PMLiVE

Actavis looks to PepsiCo for CFO

Maria Teresa Hilado will help guide company through Allergan aquisition

- PMLiVE

Actavis to buy Allergan for $66bn

Ends Valeant’s pursuit of Botox maker

- PMLiVE

EMA leaderless as tribunal forces Guido Rasi out

Court annuls appointment of executive director due to selection process concerns

- PMLiVE

Pfizer signs $2.85bn immuno-oncology alliance

Will jointly develop Merck KGaA's lead anti-PD-L1 drug

- PMLiVE

Life sciences minister: Go digital for NHS savings

Greater use of health technology could free funds for drug spending, says George Freeman

- PMLiVE

GSK tops pharma access to medicines table

But corruption and intellectual property issues in developing nations

UK unveils digital health strategy

Plans greater use of mobile technology and will track NHS 'digital health maturity'

Sanofi reception

Sanofi persuades FDA to back its MS drug Lemtrada

But only for a limited patient population, with boxed warnings and a risk plan

UK flag

UK knows ‘almost nothing’ about pancreatic cancer

Celgene-sponsored survey shows 64% of people know little about the disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links